Cargando…
Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation
Doublecortin-like kinase 1 (DCLK1), a microtubule associated kinase, has recently been proposed to be a putative marker for stemness and adverse prognosis in gastrointestinal cancers. However, it is not clear whether the protein also plays similar roles in breast cancer. Here, the expression of DCLK...
Autores principales: | Liu, Yu-Hong, Tsang, Julia Y.S., Ni, Yun-Bi, Hlaing, Thazin, Chan, Siu-Ki, Chan, Kui-Fat, Ko, Chun-Wai, Mujtaba, S. Shafaq, Tse, Gary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811473/ https://www.ncbi.nlm.nih.gov/pubmed/26621833 |
Ejemplares similares
-
FGFR1 is an adverse outcome indicator for luminal A breast cancers
por: Shi, Yu-Jie, et al.
Publicado: (2015) -
Autoregulatory control of microtubule binding in doublecortin-like kinase 1
por: Agulto, Regina L, et al.
Publicado: (2021) -
Discovery of a selective inhibitor of Doublecortin Like Kinase 1
por: Ferguson, Fleur M., et al.
Publicado: (2020) -
Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation
por: Shin, Euikyung, et al.
Publicado: (2013) -
Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability
por: Lu, Yuxiong, et al.
Publicado: (2018)